arrow
K

Kristian Brock

University of Birmingham
H指数:22
被引数:2,025

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension

国际头痛学会特发性颅内高压对照临床试验指南

2023-09-036
OA
Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision
2022-12-0115
OA
Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension

在特发性颅内高压中使用遥测监测评估昼夜和姿势颅内压

2022-11-0115
OAAI
WFS1-Associated Optic Neuropathy: Genotype-Phenotype Correlations and Disease Progression
2022-09-0112
OAAI
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial
2022-02-0123
OAAI
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation
2021-02-1711
OAAI
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study
2021-02-01115
OAAI
A robust enhancement of cytokine production in a human chronic activation model of T cell exhaustion in vitro through blockade of PD-1/PDL-1 interactions using pembrolizumab or nivolumab; correlation with dissociated tumor immune cell responses
2020-08-150
PRE
CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
2020-04-0110
OAAI